Works by Hutchings, Martin

Results: 63
    1
    2

    High‐dose therapy followed by autologous stem cell transplantation emerges as the preferred salvage therapy in patients with limited‐stage Hodgkin lymphoma progressing/relapsing after initial therapy: A subset analysis of the EORTC/LYSA/FIL H10 trial

    Published in:
    HemaSphere, 2025, v. 9, n. 4, p. 1, doi. 10.1002/hem3.70105
    By:
    • Manuel, Gotti;
    • Stepanishyna, Yana;
    • Skrypets, Tetiana;
    • Marcheselli, Luigi;
    • Cristinelli, Caterina;
    • Botto, Barbara;
    • Tonino, Sanne;
    • Cavalieri, Doriane;
    • Pulsoni, Alessandro;
    • Hutchings, Martin;
    • Hammoud, Mohammad;
    • Fortpied, Catherine;
    • Rigacci, Luigi;
    • Plattel, Wouter;
    • André, Marc;
    • Federico, Massimo
    Publication type:
    Article
    3
    4

    Safety and efficacy of parsaclisib in combination with obinutuzumab and bendamustine in patients with relapsed or refractory follicular lymphoma (CITADEL‐102): A phase 1 study.

    Published in:
    Hematological Oncology, 2023, v. 41, n. 5, p. 848, doi. 10.1002/hon.3209
    By:
    • Hamadani, Mehdi;
    • Coleman, Morton;
    • Boccia, Ralph;
    • Duras, Juraj;
    • Hutchings, Martin;
    • Zinzani, Pier Luigi;
    • Cordoba, Raul;
    • Oreiro, Mariana Bastos;
    • Williams, Vanessa;
    • Liu, Huiqing;
    • Stouffs, Michael;
    • Langmuir, Peter;
    • Sancho, Juan‐Manuel
    Publication type:
    Article
    5

    Brentuximab vedotin plus doxorubicin, vinblastine, and dacarbazine in patients with advanced‐stage, classical Hodgkin lymphoma: A prespecified subgroup analysis of high‐risk patients from the ECHELON‐1 study.

    Published in:
    Hematological Oncology, 2021, v. 39, n. 2, p. 185, doi. 10.1002/hon.2838
    By:
    • Hutchings, Martin;
    • Radford, John;
    • Ansell, Stephen M.;
    • Illés, Árpád;
    • Sureda, Anna;
    • Connors, Joseph M.;
    • Sýkorová, Alice;
    • Shibayama, Hirohiko;
    • Abramson, Jeremy S.;
    • Chua, Neil S.;
    • Friedberg, Jonathan W.;
    • Kořen, Jan;
    • LaCasce, Ann Steward;
    • Molina, Lysiane;
    • Engley, Gerald;
    • Fenton, Keenan;
    • Jolin, Hina;
    • Liu, Rachael;
    • Gautam, Ashish;
    • Gallamini, Andrea
    Publication type:
    Article
    6
    7

    Work and education interruption in long-term Hodgkin lymphoma survivors: an analysis among patients from nine EORTC-LYSA trials.

    Published in:
    Acta Oncologica, 2023, v. 62, n. 7, p. 744, doi. 10.1080/0284186X.2023.2195561
    By:
    • Juul, Sidsel J.;
    • Rossetti, Sára;
    • Kicinski, Michal;
    • van der Kaaij, Marleen A. E.;
    • Giusti, Francesco;
    • Meijnders, Paul;
    • Aleman, Berthe M. P.;
    • Raemaekers, John M. M.;
    • Kluin-Nelemans, Hanneke C.;
    • Spina, Michele;
    • Fermé, Christophe;
    • Renaud, Loïc;
    • Casasnovas, Olivier;
    • Stamatoullas, Aspasia;
    • André, Marc;
    • Le Bras, Fabien;
    • Plattel, Wouter J.;
    • Henry-Amar, Michel;
    • Hutchings, Martin;
    • Maraldo, Maja V.
    Publication type:
    Article
    8

    Interobserver delineation uncertainty in involved-node radiation therapy (INRT) for early-stage Hodgkin lymphoma: on behalf of the Radiotherapy Committee of the EORTC lymphoma group.

    Published in:
    Acta Oncologica, 2017, v. 56, n. 4, p. 608, doi. 10.1080/0284186X.2017.1279750
    By:
    • Aznar, Marianne C.;
    • Girinsky, Theodore;
    • Berthelsen, Anne Kiil;
    • Aleman, Berthe;
    • Beijert, Max;
    • Hutchings, Martin;
    • Lievens, Yolande;
    • Meijnders, Paul;
    • Meidahl Petersen, Peter;
    • Schut, Deborah;
    • Maraldo, Maja V.;
    • van der Maazen, Richard;
    • Specht, Lena
    Publication type:
    Article
    9

    Employment situation among long-term Hodgkin lymphoma survivors in Europe: an analysis of patients from nine consecutive EORTC-LYSA trials.

    Published in:
    Journal of Cancer Survivorship, 2024, v. 18, n. 3, p. 727, doi. 10.1007/s11764-022-01305-w
    By:
    • Juul, Sidsel J.;
    • Rossetti, Sára;
    • Kicinski, Michal;
    • van der Kaaij, Marleen A. E.;
    • Giusti, Francesco;
    • Meijnders, Paul;
    • Aleman, Berthe M. P.;
    • Raemaekers, John M. M.;
    • Kluin-Nelemans, Hanneke C.;
    • Spina, Michele;
    • Fermé, Christophe;
    • Renaud, Loïc;
    • Casasnovas, Olivier;
    • Stamatoullas, Aspasia;
    • André, Marc;
    • Le Bras, Fabien;
    • Plattel, Wouter J.;
    • Henry-Amar, Michel;
    • Hutchings, Martin;
    • Maraldo, Maja V.
    Publication type:
    Article
    10

    Long‐term cause‐specific mortality in adolescent and young adult Hodgkin lymphoma patients treated with contemporary regimens—A nationwide Danish cohort study.

    Published in:
    British Journal of Haematology, 2024, v. 205, n. 4, p. 1374, doi. 10.1111/bjh.19586
    By:
    • Rossetti, Sára;
    • Juul, Sidsel Jacobsen;
    • Eriksson, Frank;
    • Warming, Peder Emil;
    • Glinge, Charlotte;
    • El‐Galaly, Tarec Christoffer;
    • Haaber Christensen, Jacob;
    • Kamper, Peter;
    • de Nully Brown, Peter;
    • Gislason, Gunnar Hilmar;
    • Vestmø Maraldo, Maja;
    • Tfelt‐Hansen, Jacob;
    • Hutchings, Martin
    Publication type:
    Article
    11

    Pulmonary diseases in patients with classical Hodgkin lymphoma relative to a matched background population: A Danish national cohort study.

    Published in:
    British Journal of Haematology, 2024, v. 205, n. 2, p. 542, doi. 10.1111/bjh.19475
    By:
    • Vandtved, Julie Haugaard;
    • Øvlisen, Andreas Kiesbye;
    • Baech, Joachim;
    • Weinrich, Ulla Møller;
    • Severinsen, Marianne Tang;
    • Maksten, Eva Futtrup;
    • Jakobsen, Lasse Hjort;
    • Glimelius, Ingrid;
    • Kamper, Peter;
    • Hutchings, Martin;
    • Specht, Lena;
    • Dahl‐Sørensen, Rasmus;
    • Christensen, Jacob Haaber;
    • El‐Galaly, Tarec C.
    Publication type:
    Article
    12
    13
    14

    Concomitant semi-quantitative and visual analysis improves the predictive value on treatment outcome of interim <sup>18</sup>F-fluorodeoxyglucose/positron-emission tomography in advanced Hodgkin lymphoma.

    Published in:
    Quarterly Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 65, n. 4, p. 410, doi. 10.23736/S1824-4785.17.02993-4
    By:
    • BIGGI, Alberto;
    • BERGESIO, Fabrizio;
    • CHAUVIE, Stephane;
    • BIANCHI, Andrea;
    • MENGA, Massimo;
    • FALLANCA, Federico;
    • HUTCHINGS, Martin;
    • GREGIANIN, Michele;
    • MEIGNAN, Michel;
    • GALLAMINI, Andrea
    Publication type:
    Article
    15
    16
    17

    ABCL-360: Glofitamab Step-Up Dosing (SUD): Updated Efficacy Data Show High Complete Response Rates in Heavily Pretreated Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL) Patients (Pts).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S394, doi. 10.1016/S2152-2650(21)01893-0
    By:
    • Carlo-Stella, Carmelo;
    • Khan, Cyrus;
    • Hutchings, Martin;
    • Offner, Fritz C.;
    • Morschhauser, Franck;
    • Bachy, Emmanuel;
    • Crump, Michael;
    • Sureda, Anna;
    • lacoboni, Gloria;
    • Haioun, Corinne;
    • Perez-Callejo, David;
    • Lundberg, Linda;
    • Relf, James;
    • Clark, Emma;
    • Carlile, David;
    • Piccione, Emily;
    • Belousov, Anton;
    • Humphrey, Kathryn;
    • Dickinson, Michael J.
    Publication type:
    Article
    18

    HL-147: Brentuximab Vedotin with Chemotherapy for Patients with Previously Untreated Stage III/IV Classical Hodgkin Lymphoma: 5-Year Update of the ECHELON-1 Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S371, doi. 10.1016/S2152-2650(21)01849-8
    By:
    • Ramchandren, Radhakrishnan;
    • Dfugosz-Danecka, Monika;
    • Connors, Joseph M.;
    • Radford, John;
    • Illés, Árpád;
    • Picardi, Marco;
    • Lech-Maranda, Ewa;
    • Feldman, Tatyana;
    • Smolewski, Piotr;
    • Savage, Kerry J.;
    • Bartlett, Nancy L.;
    • Walewski, Jan;
    • Zinzani, Pier Luigi;
    • Hutchings, Martin;
    • Munoz, Javier;
    • Won Seog Kim;
    • Advani, Ranjana;
    • Ansell, Stephen M.;
    • Gallamini, Andrea;
    • Alekseev, Sergey
    Publication type:
    Article
    19

    Poster:ABCL-360 Glofitamab Step-Up Dosing (SUD): Updated Efficacy Data Show High Complete Response Rates in Heavily Pretreated Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL) Patients (Pts).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S243, doi. 10.1016/S2152-2650(21)01526-3
    By:
    • Carlo-Stella, Carmelo;
    • Khan, Cyrus;
    • Hutchings, Martin;
    • Offner, Fritz C.;
    • Morschhauser, Franck;
    • Bachy, Emmanuel;
    • Crump, Michael;
    • Sureda, Anna;
    • Iacoboni, Gloria;
    • Haioun, Corinne;
    • Perez-Callejo, David;
    • Lundberg, Linda;
    • Relf, James;
    • Clark, Emma;
    • Carlile, David;
    • Piccione, Emily;
    • Belousov, Anton;
    • Humphrey, Kathryn;
    • Dickinson, Michael J.
    Publication type:
    Article
    20

    Poster: HL-147: Brentuximab Vedotin with Chemotherapy for Patients with Previously Untreated Stage III/IV Classical Hodgkin Lymphoma: 5-Year Update of the ECHELON-1 Study.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S236, doi. 10.1016/S2152-2650(21)01485-3
    By:
    • Ramchandren, Radhakrishnan;
    • Długosz-Danecka, Monika;
    • Connors, Joseph M.;
    • Radford, John;
    • Illés, Árpád;
    • Picardi, Marco;
    • Lech-Maranda, Ewa;
    • Feldman, Tatyana;
    • Smolewski, Piotr;
    • Savage, Kerry J.;
    • Bartlett, Nancy L.;
    • Walewski, Jan;
    • Zinzani, Pier Luigi;
    • Hutchings, Martin;
    • Munoz, Javier;
    • Won Seog Kim;
    • Advani, Ranjana;
    • Ansell, Stephen M.;
    • Gallamini, Andrea;
    • Alekseev, Sergey
    Publication type:
    Article
    21

    Oral Abstract: ABCL-360: Glofitamab Step-Up Dosing (SUD): Updated Efficacy Data Show High Complete Response Rates in Heavily Pretreated Relapsed/Refractory (R/R) Non-Hodgkin Lymphoma (NHL) Patients (Pts).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S203, doi. 10.1016/S2152-2650(21)01279-9
    By:
    • Carlo-Stella, Carmelo;
    • Khan, Cyrus;
    • Hutchings, Martin;
    • Offner, Fritz C.;
    • Morschhauser, Franck;
    • Bachy, Emmanuel;
    • Crump, Michael;
    • Sureda, Anna;
    • Iacoboni, Gloria;
    • Haioun, Corinne;
    • Perez-Callejo, David;
    • Lundberg, Linda;
    • Relf, James;
    • Clark, Emma;
    • Carlile, David;
    • Piccione, Emily;
    • Belousov, Anton;
    • Humphrey, Kathryn;
    • Dickinson, Michael J.
    Publication type:
    Article
    22

    FDG-PET/CT based response-adapted treatment.

    Published in:
    Cancer Imaging, 2012, v. 12, n. 2, p. 324, doi. 10.1102/1470-7330.2012.9006
    By:
    • de Geus-Oei, Lioe-Fee;
    • Vriens, Dennis;
    • Arens, Anne I. J.;
    • Hutchings, Martin;
    • Oyen, Wim J. G.
    Publication type:
    Article
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33

    Long‐term overall survival and toxicities of ABVD vs BEACOPP in advanced Hodgkin lymphoma: A pooled analysis of four randomized trials.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 18, p. 6565, doi. 10.1002/cam4.3298
    By:
    • André, Marc P. E.;
    • Carde, Patrice;
    • Viviani, Simonetta;
    • Bellei, Monica;
    • Fortpied, Catherine;
    • Hutchings, Martin;
    • Gianni, Alessandro M.;
    • Brice, Pauline;
    • Casasnovas, Olivier;
    • Gobbi, Paolo G.;
    • Zinzani, Pier Luigi;
    • Dupuis, Jehan;
    • Iannitto, Emilio;
    • Rambaldi, Alessandro;
    • Brière, Josette;
    • Clément‐Filliatre, Laurianne;
    • Heczko, Marian;
    • Valagussa, Pinuccia;
    • Douxfils, Jonathan;
    • Depaus, Julien
    Publication type:
    Article
    34
    35

    Little value of surveillance magnetic resonance imaging for primary CNS lymphomas in first remission: results from a Danish Multicentre Study.

    Published in:
    British Journal of Haematology, 2017, v. 176, n. 4, p. 671, doi. 10.1111/bjh.13988
    By:
    • Mylam, Karen Juul;
    • Michaelsen, Thomas Yssing;
    • Hutchings, Martin;
    • Jacobsen Pulczynski, Elisa;
    • Pedersen, Lars Møller;
    • Brændstrup, Peter;
    • Gade, Inger Lise;
    • Eberlein, Tobias Ramm;
    • Gang, Anne Ortved;
    • Bøgsted, Martin;
    • Brown, Peter de Nully;
    • El ‐ Galaly, Tarec Christoffer
    Publication type:
    Article
    36
    37

    Uterine, but not ovarian, female reproductive organ involvement at presentation by diffuse large B-cell lymphoma is associated with poor outcomes and a high frequency of secondary CNS involvement.

    Published in:
    British Journal of Haematology, 2016, v. 175, n. 5, p. 876, doi. 10.1111/bjh.14325
    By:
    • El ‐ Galaly, Tarec Christoffer;
    • Cheah, Chan Y.;
    • Hutchings, Martin;
    • Mikhaeel, Nabegh George;
    • Savage, Kerry J.;
    • Sehn, Laurie H.;
    • Barrington, Sally;
    • Hansen, Jakob W.;
    • Poulsen, Mette Ø.;
    • Smith, Daniel;
    • Rady, Kirsty;
    • Mylam, Karen J.;
    • Larsen, Thomas S.;
    • Holmberg, Staffan;
    • Juul, Maja B.;
    • Cordua, Sabrina;
    • Clausen, Michael R.;
    • Jensen, Kristina B.;
    • Bøgsted, Martin;
    • Johnsen, Hans E.
    Publication type:
    Article
    38
    39

    A population-based study of prognosis in advanced stage follicular lymphoma managed by watch and wait.

    Published in:
    British Journal of Haematology, 2015, v. 169, n. 3, p. 435, doi. 10.1111/bjh.13316
    By:
    • El‐Galaly, Tarec Christoffer;
    • Bilgrau, Anders E.;
    • Nully Brown, Peter;
    • Mylam, Karen J.;
    • Ahmad, Syed A.;
    • Pedersen, Lars M.;
    • Gang, Anne O.;
    • Bentzen, Hans H.;
    • Juul, Maja B.;
    • Bergmann, Olav J.;
    • Pedersen, Robert S.;
    • Nielsen, Berit J.;
    • Johnsen, Hans E.;
    • Dybkær, Karen;
    • Bøgsted, Martin;
    • Hutchings, Martin
    Publication type:
    Article
    40

    Risk of Cardiovascular Disease in Patients With Classical Hodgkin Lymphoma: A Danish Nationwide Register‐Based Cohort Study.

    Published in:
    European Journal of Haematology, 2025, v. 114, n. 2, p. 343, doi. 10.1111/ejh.14334
    By:
    • Godtfredsen, Sissel J.;
    • Yonis, Harman;
    • Baech, Joachim;
    • Al‐Hussainy, Nour R.;
    • Riddersholm, Signe;
    • Kober, Lars;
    • Schou, Morten;
    • Christensen, Jacob Haaber;
    • Hutchings, Martin;
    • Dahl‐Sørensen, Rasmus Bo;
    • Kamper, Peter;
    • Dietrich, Caroline E.;
    • Andersen, Mikkel Porsborg;
    • Torp‐Pedersen, Christian;
    • Sogaard, Peter;
    • El‐Galaly, Tarec Christoffer;
    • Kragholm, Kristian H.
    Publication type:
    Article
    41

    Comparison of outcomes between Hodgkin's lymphoma patients treated in and outside clinical trials: A study based on the EORTC‐Dutch late effects cohort‐linked data.

    Published in:
    European Journal of Haematology, 2023, v. 110, n. 3, p. 243, doi. 10.1111/ejh.13899
    By:
    • Juul, Sidsel Jacobsen;
    • Kicinski, Michal;
    • Schaapveld, Michael;
    • Rossetti, Sára;
    • Aleman, Berthe M. P.;
    • Liu, Lifang;
    • van Leeuwen, Flora E.;
    • Meijnders, Paul;
    • Krol, Augustinus D. G.;
    • Janus, Cécile P. M.;
    • Hutchings, Martin;
    • Maraldo, Maja V.
    Publication type:
    Article
    42

    Reference values for the EORTC QLQ‐C30 in patients with advanced stage Hodgkin lymphoma and in Hodgkin lymphoma survivors.

    Published in:
    European Journal of Haematology, 2021, v. 106, n. 5, p. 697, doi. 10.1111/ejh.13601
    By:
    • Vachon, Hugo;
    • Mierzynska, Justyna;
    • Taye, Mekdes;
    • Pe, Madeline;
    • Coens, Corneel;
    • Martinelli, Francesca;
    • Fortpied, Catherine;
    • Flechtner, Hans‐Henning;
    • Vestmoe Maraldo, Maja;
    • Hutchings, Martin;
    • Meijnders, Paul;
    • Aleman, Berthe;
    • Lugtenburg, Pieternella;
    • Spina, Michele;
    • André, Marc;
    • Hertzberg, Mark;
    • Briones, Javier;
    • Bottomley, Andrew
    Publication type:
    Article
    43
    44
    45
    46

    Subcutaneous Epcoritamab in Patients With Relapsed or Refractory Large B-Cell Lymphoma (EPCORE NHL-1): Pivotal Results From a Phase 2 Study.

    Published in:
    Acta Haematologica Polonica, 2022, v. 53, n. A, p. 44
    By:
    • Jurczak, Wojciech;
    • Thieblemont, Catherine;
    • Phillips, Tycel;
    • Ghesquieres, Herve;
    • Cheah, Chan Y.;
    • Roost, Michael;
    • Cunningham, David;
    • Young Rok Do;
    • Feldman, Tatyana;
    • Gasiorowski, Robin;
    • Tae Min Kim;
    • Lewis, David John;
    • Van der Poel, Marjolein;
    • Limei Poon, Michelle;
    • Doerr, Thomas;
    • Kilavuz, Nurgul;
    • Menghui Chen;
    • Sacchi, Mariana;
    • Elliott, Brian;
    • Hutchings, Martin
    Publication type:
    Article
    47

    NOTCH1 Mutations Are Associated With Therapy‐Resistance in Patients With B‐Cell Lymphoma Treated With CD20xCD3 Bispecific Antibodies.

    Published in:
    American Journal of Hematology, 2025, v. 100, n. 4, p. 712, doi. 10.1002/ajh.27601
    By:
    • Kyvsgaard, Emil R.;
    • Grauslund, Morten;
    • Sjø, Lene;
    • Melchior, Linea Cecilie;
    • Grantzau, Trine Lønbo;
    • Gjerdrum, Lise Mette Rahbek;
    • Trab, Trine;
    • Andersen, Lærke Sloth;
    • Gang, Anne Ortved;
    • Breinholt, Marie;
    • Møller, Michael Boe;
    • Haaber Christensen, Jacob;
    • Larsen, Thomas Stauffer;
    • Clausen, Michael Roost;
    • Riley, Caroline H.;
    • Niemann, Carsten U.;
    • Grønbæk, Kirsten;
    • Hutchings, Martin;
    • Husby, Simon
    Publication type:
    Article
    48
    49

    Outcome prediction by extranodal involvement, IPI, R-IPI, and NCCN-IPI in the PET/CT and rituximab era: A Danish- Canadian study of 443 patients with diffuse-large B-cell lymphoma.

    Published in:
    American Journal of Hematology, 2015, v. 90, n. 11, p. 1041, doi. 10.1002/ajh.24169
    By:
    • El-Galaly, Tarec Christoffer;
    • Villa, Diego;
    • Alzahrani, Musa;
    • Hansen, Jakob Werner;
    • Sehn, Laurie H.;
    • Wilson, Don;
    • de Nully Brown, Peter;
    • Loft, Annika;
    • Iyer, Victor;
    • Johnsen, Hans Erik;
    • Savage, Kerry J.;
    • Connors, Joseph M.;
    • Hutchings, Martin
    Publication type:
    Article
    50